Point-of-Care/Contact HIV Testing

Poster #1: HIV Test Preferences in an Urban Hospital Emergency Department

  1. Calderon, E. Cowan, J. Fettig, J. Nickerson, J. Leider

1Jacobi Medical Center, Bronx, NY

2Albert Einstein College of Medicine, Bronx, NY

Poster #2: Aware™ in retrospective: a multi-year, multi-country evaluation of an oral fluid HIV-1/2 Rapid Test.

CW Hooker

Calypte Biomedical Corporation Portland, OR USA

Poster #3: Rapid HIV Testing Programs in Urban Emergency Departments – Comparison of Results from Inner-City and Urban Sites in Baltimore, Maryland

Y.-H. Hsieh, L. Harvey, A. Burah, R.E. Rothman

Department of Emergency Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland

Poster #4: HIV Rapid Testing Quality Assurance Program and Evaluation of HIV Rapid testing technologies in Ethiopia

Getachew Belay, Belete Tegbaru, Gudeta Tibesso

Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa, Ethiopia

Poster #5: RETESTING AS A TOOL FOR QUALITY ASSURANCE OF HIV RAPID TEST AT POINT-OF-CARE IN RESOURCE LIMITED SETTINGS

I.M. Livinus1, M. Okoye2, E. Iwe1, O. Salami1, E. Omorogbe1, C. Ntagbu3, D. Olorunmeye4.

1Management Sciences for Health, Abuja-Nigeria

2United States Agency for International Development, Abuja-Nigeria

3HIV Research Lab Division, General Hospital New Bussa, Niger State

4State Specialist Hospital Lokoja, Kogi State

Poster #6: Assessment of HIV test Discordance in a Serial Testing Algorithm

M.I.J Okoye (USAID/NIGERIA, Abuja, FCT, Nigeria), L. Okoye (FHI/GHAIN, Abuja, FCT, Nigeria), I. Wurie (CDC/Nigeria, Abuja, FCT, Nigeria)

Poster #7: Single Rapid HIV Testing and Entry into Care: Experience in New Jersey, 2005 – 2006

  1. Piatek, S. Paul, A. Ibrahim, P. Fleming, K. Delaney

UMDNJ, School of Public Health, Newark, NJ, USA NJ Dept of Health and Senior Services, Division of HIV/AIDS, Trenton, NJ, USA NJ Dept of Health and Senior Services, Division of HIV/AIDS, Trenton, NJ, USA UMDNJ, NJ Medical School and School of Public Health, Newark, NJ CDC, Division of HIV/AIDS Prevention, Atlanta, GA, USA

Poster #8: Evaluating and balancing quality and costs in rapid HIV Quality Assurance

Salaru G, Cadoff EM, Paul SM, and Martin EG

UMDNJ – Robert Wood Johnson Medical School, Department of Pathology & Laboratory Medicine, Somerset, NJ.

Poster #9: Performance of a Rapid HIV Test as the Primary Screening Tool at a Community Health Center in Houston, Texas

Scott, J*.,Turner, C., York, S., Broussard, T., and Pottumarthy, S.

Bureau of Laboratory Services, Houston Department of Health and Human Services, Houston, TX, USA

Poster #10: Performance of the OraQuick Advance® Rapid HIV-1/2 test in a HIP HOP for HIV Awareness and Intervention Program in Houston, Texas

York, S.,* Turner, C., Scott, J., and Pottumarthy, S.

Bureau of Laboratory Services, Houston Department of Health and Human Services, Houston, TX, USA.

Poster #11: Improved Oral Fluid Specificity of the Enhanced OraQuick ADVANCE Rapid HIV 1/2 Oral Fluid Antibody Test

  1. Guillon, K.W. Kardos, L. Kriebel, S.R. Lee

OraSure Technologies, Inc., Bethlehem, PA, USA

 

 

Bridging Point-of-Care/Contact & Laboratory Testing

Poster #12: Translation isn’t just about foreign language: bridging the language gap with HIV testing

  1. Facente

Facente Consulting, San Francisco, CA, USA

Poster #13: Using photographed rapid HIV test results to pilot an EQAS

Chiu C, Ong J, Walker S and Dax EM

National Serology Reference Laboratory, Australia; St Vincent’s Institute, Fitzroy, Australia

Poster #14: The Significance and Value of External Quality Assessment for HIV-1 Testing

  1. Taylor and EM. Dax

National Serology Reference Laboratory, Australia, 41 Victoria Parade, Fitzroy 3065

Poster #15: Comparison of Dried Tube and Plasma Specimens in an External Quality Assurance (EQA) Scheme and Evaluation of Quality of HIV Rapid Testing Performed by Non-Laboratory Staff in Lesotho.

  1. Lewis, M. Leqheka, M. LEBINA, D. Mothabeng, Y. Mengistu, B. Parekh, J. Nkengasong, J. Creighton, R. Timperi.

APHL, Silver Spring, MD, CDC/GAP ILB; CDC Lesotho, and Lesotho Ministry of Health and Social Welfare (MOHSW)

 

Serologic HIV Testing Methods

Poster #16: Correlation of preliminary positive HIV antibody assays performed on the ADViA Centaur CIA to WB: A one year look back

  1. Levine, K. Yi, M. Narlieva, G. Moskaleva, and A. Fox

Montefiore Medical Center, Bronx, New York, USA

Poster #17: Is positive antibody detection on a chemiluminescence (CIA) HIV immunoassay in the presence of a negative western blot (WB) always a false positive?

  1. Levine, K. Yi, M. Narlieva, and A. Fox

Montefiore Medical Center, Bronx, NY, USA

Poster #18: The High Positive Immunoassay Confirms HIV-1 Infection and Avoids the Need of Confirmatory Tests

  1. J. Ochoa-Jiménez, M. Ríos-Silva, J. Cortez-Mares, A. M. Contreras, L. Dávalos-Gómez, B. Trujillo-Hernández.

The Department of Internal Medicine and the Clinic of Sexually Transmitted Diseases, Regional Hospital of Colima; the Department of Internal Medicine, General Hospital 1, Colima, and the Health Research Council in Jalisco State, Mexican Institute of Social Security.

Poster #19: Evaluation of the ADVIA Centaur® HIV 1/O/2 Enhanced (EHIV) Assay

  1. Pyne, R. Roberts, S. Griffiths, R. Bradley, and P. Slev

ARUP Laboratories, Salt Lake City, UT, USA

Poster #20: Validating supplemental oral fluid testing for preliminary positive rapid HIV tests

  1. Constantine, Fassil Ketema, Laura Wesolowski, Ernilyn Bosco, Ahmed R. Saleh, Jeff Gray, Mary Ann Sandrino, Steven Ethridge

University of Maryland School of Medicine, CDC, UMMS, Cairo Univ Faculty of Science Baltimore, MD 21201, USA

Poster #21: Correlation on the Use of a Reactive Signal to Cutoff Threshold Value in a 3rd Generation HIV-1/2 Antibody Immunoassay to Expedite Supplemental Testing and Reduce Screening Costs

  1. Bennett1, S. Fordan1, M Diamante2, M. Salfinger1,2, R. Batchelor1, D. Willis1, S. Crowe1

Florida Department of Health, Bureau of Laboratories-(Jacksonville1, Miami2) FL., USA

Poster #22: Performance of the Ortho Vitros HIV1/2 Assay in a Pregnant Population, Including at Delivery

  1. J. Loeffelholz1 and J. A. Patel2

Departments of Pathology1 and Pediatrics2, University of Texas Medical Branch, Galveston, Texas 77555

 

 

Testing for Recent HIV Infection

Poster #23: Standardization and Monitoring of Laboratory Performance and Quality Assurance Using the Less-Sensitive HIV Incidence Assay: Seven Years of Results

J.V. Mei, M. Kennedy, L. Linley, D. Hanson, J. Schiffer, S. Ethridge, B. Branson

Centers for Disease Control and Prevention, Atlanta, Georgia USA

Poster #24: Development of a Bead-based, Multiplex Assay for Estimation of Recent HIV-1 Infection

Kelly A. Curtis, M. Susan Kennedy, Debra Candal, Debra Hanson, Kevin Delaney, Man Charurat, Steve McDougal and S. Michele Owen

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Poster #25: Fiebig Stage and Recency: What’s the Relationship?

PE Garrett, M Manak and MP Busch

SeraCare Life Sciences and Blood Systems Research Institute Milford, MA and San Francisco, CA

 

 

Fourth Generation Immunoassays

Poster #26: Seroconversion Panels for the Validation of 3rd and 4th Generation HIV Assays

  1. R. Chiklis Ph.D. and J.C.D. Hengst Ph.D.

ZeptoMetrix Corporation, 872 Main Street, Buffalo, NY 14202

 

 

Applications of Nucleic Acid Testing Technologies

Poster #27: Evaluation of HIV RNA detection to increase ascertainment of primary HIV infection

G Murphy, S.Carne, B.Patel, C. Hill, A.Charlett, E.Mckinney, O.N. Gill, J.V. Parry and J. Tosswill

Poster #28: Evaluation of an FDA-approved qualitative RNA detection assay for diagnosis of HIV-1 infection in perinatally exposed infants

  1. J. Sullivan, T. T. Miller, B. Warren, and M. M. PARKER

Wadsworth Center, New York State Department of Health, Albany, NY

Poster #29: An evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing

  1. J. Sullivan, M. M. Parker, S. F. Ethridge, Pragna Patel

Wadsworth Center, New York State Department of Health, Albany NY Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta GA

Poster #30: A High Throughput, Cost Effective System for Acute HIV Detection in Health Department STD Clinics, New York City, May 5, 2008 – September 16, 2009

Goldsmith J*, Smith R*, Kowalski A, Blank, S, Faruki H*

*National Genetics Institute, Laboratory Corporation of America, Los Angeles, CA

Poster #31: Sensitivity of OraQuick and Early Generation Enzyme Immunoassay (EIA) within a Pooled HIV Nucleic Acid Amplification Testing (HIV NAAT) Program

J Stekler1,2, PD Swenson2, RW Coombs1, J Dragavon1, RW Wood1,2, MR Golden1,2

1University of Washington, Seattle, WA

2Public Health – Seattle & King County, WA

 

New Approaches in HIV Testing

Poster #32: Evaluation of Dried Blood Spots for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing

Dawit Assefa1, Woldaregay Eriku2, Teferi Gedif2, Belete Tegbaru1, Dereje Teshome1, Tesfaye Tilahun1, Hiwot Birhanu1, Mesfin Kebede1, Almaz Abebe1

1Ethiopian Health and Nutrition Research Institute

2Addis Ababa University

Poster #33: Continued Repetitive HIV Western Blot Testing Post-HIV Diagnosis and Association with Care Engagement

Weis KE, Stephens T, Gibson JJ, Duffus WA

School of Medicine, University of South Carolina, Columbia, SC South Carolina Department of Health and Environmental Control, Columbia, SC

Poster #34: Evaluation of the IsoAmp® HIV detection kit Using Whole Blood Samples

J.A. Jordan, O.C. Ibe, G. Simon

The George Washington University, School of Public Health and Health Services, Washington, DC

Poster #35: Identification of Performance problems in the Abbott HIV-1&2 gO EIA by multiuser external quality control monitoring and real-time data analysis.

  1. Kim, C. Swantee, B. Lee, H. Gunning, A. Chow, F. Sidaway, C. Sherlock, R. Garceau, W. Dimech, L. Malloch and CAHCLS Laboratories.

National Laboratory for HIV Reference Services, Public Health Agency of Canada, Ottawa, Ontario.

Poster #36: Rapid extraction and amplification of HIV-1 DNA from whole blood using a disposable microfluidics device

Timothy C. Granade1, Susan K. Wells1, Joan Haab2, John Gerdes2, Sabrina Gates2, Michele Owen1 and Chou-Pong Pau1

1Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA

2Micronics, Inc., Redmond, WA

Poster #37: A Rapid Portable HIV Detection & Monitoring System for Low Resource Settings

Joel W. Grover, Ph.D.1 and Katherine Luzuriaga, M.D.2

1Thermal Gradient Inc, Pittsford, NY, USA

2UMass Medical School, Worcester, MA, USA

Poster #38: Detection of Human Immunodeficiency Virus Type 2 (HIV-2) Using a Real Time RT-PCR Assay with a Whole Virus Internal Control

Linda M. Styer, Binshan Shi, and Monica M. Parker

Wadsworth Center, New York State Department of Health, Albany, NY School of Public Health, University of Albany, Albany, NY

Poster #39: Development of a simple, rapid and inexpensive method for the qualitative detection of HIV-1 RNA

Chou-Pong Pau, Susan K. Wells, S. Michele Owen, and Timothy C. Granade.

Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, Ga  30329

Poster #40: Innovative point-of-care HIV viral load detection in RLS

  1. Laser, L. Mazzola, A. Arsham, A. Pedersen, R. Bhatia and D. Stern

Wave 80 Biosciences, San Francisco, CA, USA

Poster #41: SMARTube™ as a Test for Recent Infection

  1. Kassanjee, A. Welte and T. Jehuda-Cohen

University of the Witwatersrand, School of Computational and Applied Mathematics, Johannesburg, South Africa; South African DST/ NRF Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch, South Africa

Poster #42: Preparation of Reference Panels for Current and Emerging HIV Variants

Mark Manak1, Bharathi Anekella1, Michael Busch2, Marion Vermeulen3, Susan Stramer4, Sodsai Tovanabutra5, Robert Coombs6, David Montefiori7, Patricia Garrett1, Marco Schito8

1SeraCare Life Sciences, Gaithersburg, MD

2Blood Systems Research Institute, San Francisco, CA

3South African National Blood Service, Johannesburg, S. Africa

4American Red Cross, Gaithersburg, MD

5U.S. Military HIV Research Program, Rockville, MD

6University of Washington, Seattle, WA

7Duke Human Vaccine Institute, Durham, NC

8Henry Jackson Foundation/DAIDS/NIH, Bethesda, MD

Poster #43: Characterization of Immune Responses to Capsid Protein (p24) of Human Immunodeficiency Virus Type 1: Implications for Detection

  1. Tang, J. Zhao, A. Wang, R. Viswanath, H. Harma, R. Little, R. Yarchoan, S. Stramer, P. Nyambi, S. Lee, O. Wood, E. Wong, X. Wang, I. Hewlett

Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, USA

Poster #44: Mother to child transmission of HIV-1 infection in UK – how soon can a diagnosis be made?

  1. Tosswill, J Masters, M. Zuckerman, D. Pillay, P. Tookey and J. Parry

Centre for Infections, Health Protection Agency, London, UK